David Seastone is an Oncology physician affiliated with UPMC Hillman Cancer Center. OpenAlex indexes 29 publications with 635 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2500 W 12th St
Erie, PA 165054500
Telephone
814-836-2600Provider last certified this registry record 29 Oct 2021.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ADC THERAPEUTICS AMERICA, INC.Program year20251 payment
- AstraZeneca Pharmaceuticals LPProgram year20242 payments
- Regeneron Healthcare Solutions, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
27.7%Aromatase Inhibitor12.7%Anastrozole75%Letrozole21%Exemestane4%Part D<11 patientsKinase inhibitor5.5%Imbruvica19%Verzenio16%Imatinib Mesylate14%Calquence13%Tasigna11%Lenvima11%Inlyta9%Tykerb7%Part D<11 patients+ 8 more classes in this area
Nervous system
26.9%Opioid Agonist13%Oxycodone Hcl43%Fentanyl18%Morphine Sulfate Er13%Tramadol Hcl9%Oxycodone-Acetaminophen8%Morphine Sulfate6%Hydromorphone Hcl3%Part D<11 patientsPhenothiazine4.1%Prochlorperazine Maleate100%Part D≥84 patients+ 4 more classes in this area
Metabolism & gastrointestinal
17.3%Corticosteroid7.7%Prednisone100%Part D≥81 patientsSerotonin-3 Receptor Antagonist3.5%Ondansetron Hcl60%Ondansetron Odt40%Part D≥29 patients+ 5 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A Phase II Trial of Personalized Immunotherapy in Patients (pts) with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M HNSCC) That Have Progressed on Prior Immunotherapy.
International Journal of Radiation Oncology*Biology*Physics
2024 - Reducing Time to Antibiotic Administration for Febrile Neutropenia in the Emergency Department
Journal of Oncology Practice
2015
Similar KOLs
Other experts from the same institution or the same specialty.
Udai Kammula, MD
UPMC Hillman Cancer Center
Amer Zureikat, MD
UPMC Hillman Cancer Center
Antoinette Wozniak, MD
UPMC Hillman Cancer Center
Mounzer Agha, MD
UPMC Hillman Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”